Teledyne Technologies Incorporated: financial analysis
Ratios worked out from 10 fiscal years of Teledyne Technologies Incorporated's statements, compared with 32 companies in Scientific Technical Instruments.
Teledyne Technologies Incorporated scorecard#
Passes 17 of the 20 checks that could be worked out: strongest in financial health (6 of 6), weakest in profitability (4 of 6). Fiscal year 2025; market cap of Sep 22, 2026.
Valuationnot known
- –P/E below its peers' medianThe market cap dates from 2026-09-22, more than 60 days ago.
- –Price to book below its peers' medianThe market cap dates from 2026-09-22, more than 60 days ago.
- –Price to sales below its peers' medianThe market cap dates from 2026-09-22, more than 60 days ago.
- –Free cash flow yield above 5%The market cap dates from 2026-09-22, more than 60 days ago.
- –Earnings yield above the 10-year Treasury yieldThe market cap dates from 2026-09-22, more than 60 days ago.
- –The price assumes slower growth than the last three years'The market cap dates from 2026-09-22, more than 60 days ago.
Growth5 of 6
- ✓Revenue grew in the newest year7.9%Revenue up 7.9% in fiscal 2025.
- ✗Revenue up more than 5% a year over three years3.9%3.9% a year over the three years to fiscal 2025.
- ✓Faster growth over three years than its peers' median3.9%3.9% a year against Scientific Technical Instruments's median of 3.0% (24 companies).
- ✓Earnings per share grew in the newest year18.88 vs 17.21Diluted EPS 18.88 in fiscal 2025 against 17.21 the year before (report's currency).
- ✓Net income higher than five years earlier$895 M$895 M in fiscal 2025 against $402 M in 2020.
- ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
Profitability4 of 6
- ✓Profitable in the newest year$895 MNet income $895 M in fiscal 2025.
- ✓Profitable in each of the last five years5 of 5Profitable in 5 of the five years to fiscal 2025.
- ✓Operating margin above its peers' median18.8%18.8% against Scientific Technical Instruments's median of 9.1% (26 companies).
- ✗Return on equity above 15%8.9%8.9% in fiscal 2025.
- ✗Return on invested capital above 10%7.8%7.8% in fiscal 2025.
- ✓Operating margin wider than three years earlier18.8%18.8% in fiscal 2025 against 17.8% in 2022.
Financial health6 of 6
- ✓Short-term assets cover short-term liabilities1.6×Current ratio 1.64 at the end of fiscal 2025.
- ✓Debt below equity0.2×Debt to equity 0.24 at the end of fiscal 2025.
- ✓Net debt below three years of EBITDA1.4×Net debt 1.4 times EBITDA in fiscal 2025.
- ✓Operating income covers interest five times19.3×Operating income 19.3 times interest in fiscal 2025.
- ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
- ✓Altman Z-score outside the distress zone4.92Z-score 4.92 (safe zone) for fiscal 2025.
Shareholder returns2 of 2
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✓Share count up no more than 2% in a year-0.4%Diluted shares down 0.4% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueThe market cap dates from 2026-09-22, more than 60 days ago.
- ✓Free cash flow covers dividends and buybacks$1.1 BFree cash flow $1.1 B against $403 M paid out in fiscal 2025.
Worked out from the statements as filed (sec), the medians of Scientific Technical Instruments, the 10-year Treasury yield of Nov 20, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
What the 2025 statements show#
Each line is an observation with its numbers, not a judgement of the company.
Strengths
- Revenue has grown 5 years in a row.
- Free cash flow has been positive 17 years in a row.
Worth a look
- Goodwill and intangibles ($10.8 billion) exceed shareholders' equity ($10.5 billion).
Piotroski F-score
Nine yes/no tests of whether the company's finances improved in the year. One point each.
- Made a profityes
- Operations brought in cashyes
- Return on assets roseyes
- Cash from operations exceeds profityes
- Long-term debt fell against assetsyes
- Current ratio roseno
- No new shares issuedyes
- Gross margin roseno
- Asset turnover roseyes
Altman Z-score
A 1968 formula that weighs five balance-sheet ratios. It was built on listed manufacturers and says less about other kinds of company.
| Part | Ratio | Weight | Points |
|---|---|---|---|
| Working capital to assets | 0.08 | × 1.2 | 0.09 |
| Retained earnings to assets | 0.47 | × 1.4 | 0.65 |
| Operating income to assets | 0.07 | × 3.3 | 0.25 |
| Market value to liabilities | 5.88 | × 0.6 | 3.53 |
| Revenue to assets | 0.40 | × 1 | 0.40 |
Where the return on equity comes from
The DuPont split: margin, times how hard the assets work, times how much of them is financed by others.
Profitability#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 42.8% | 42.9% | 43.3% | 42.7% | 39.9% | 44.4% | 46% | |
| Operating margin | 18.8% | 17.4% | 18.4% | 17.8% | 13.5% | 9.1% | 88% | |
| Net margin | 14.6% | 14.5% | 15.7% | 14.5% | 9.7% | 8.7% | 77% | |
| Return on equity | 8.9% | 8.7% | 10.2% | 10.0% | 8.2% | 3.9% | 63% | |
| Return on assets | 6.1% | 5.7% | 6.1% | 5.5% | 4.6% | 1.7% | 68% | |
| Return on invested capital | 7.8% | 7.4% | 8.2% | 7.4% | 7.1% | 7.8% | 50% |
Growth#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | 7.9% | 0.6% | 3.2% | 18.3% | 49.5% | 4.0% | 63% | |
| Revenue growth, 3 years a year | 3.9% | 7.1% | 22.2% | 19.9% | 16.7% | 3.0% | 52% | |
| Revenue growth, 5 years a year | 14.7% | 12.4% | 14.2% | 16.0% | 16.5% | 4.6% | 91% | |
| Net income growth | 9.2% | -7.5% | 12.3% | 77.1% | 10.8% | 7.8% | 56% | |
| Earnings per share growth | 9.7% | -6.9% | 11.9% | 64.5% | -5.4% | 9.7% | 53% |
Financial strength#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Debt to equity | 0.24× | 0.28× | 0.35× | 0.48× | 0.54× | 0.32× | 77% | |
| Net debt | $2.1 B | $2.0 B | $2.6 B | $3.3 B | $3.6 B | $165 M | 15% | |
| Net debt to EBITDA | 1.43× | 1.54× | 1.92× | 2.52× | 3.64× | 1.05× | 43% | |
| Interest cover | 19.29× | 17.08× | 13.38× | 10.88× | 6.88× | -5.13× | 100% | |
| Current ratio | 1.64× | 2.33× | 1.69× | 1.85× | 1.62× | 2.57× | 27% | |
| Equity share of assets | 68.8% | 67.3% | 63.5% | 56.9% | 52.8% | 59.1% | 65% |
Cash#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Free cash flow | $1.1 B | $1.1 B | $721 M | $394 M | $723 M | $6 M | 92% | |
| Free cash flow margin | 17.6% | 19.5% | 12.8% | 7.2% | 15.7% | 14.3% | 73% | |
| Cash conversion | 133.1% | 145.5% | 94.4% | 61.7% | 185.2% | 134.8% | 44% | |
| Capital spending share of revenue | 1.9% | 1.5% | 2.0% | 1.7% | 2.2% | 2.2% | — |
Efficiency#
| Fiscal year | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Asset turnover | 0.41× | 0.39× | 0.39× | 0.38× | 0.47× | 0.58× | 15% |
How each figure is worked out#
- Gross margin
- Gross profit as a share of revenue.
- Operating margin
- Operating income as a share of revenue.
- Net margin
- Net income as a share of revenue.
- Return on equity
- Net income as a share of shareholders' equity (the average of the start and the end of the year). Not given when equity is negative.
- Return on assets
- Net income as a share of total assets (average of the year).
- Return on invested capital
- Operating income after tax, as a share of debt plus equity less cash (average of the year). The tax rate is the year's own: income tax over pre-tax income.
- Revenue growth
- Revenue against the year before.
- Revenue growth, 3 years a year
- The yearly rate that takes revenue of three years earlier to this year's.
- Revenue growth, 5 years a year
- The yearly rate that takes revenue of five years earlier to this year's.
- Net income growth
- Net income against the year before. Only when both years were profitable.
- Earnings per share growth
- Diluted earnings per share against the year before. Only when both were positive.
- Debt to equity
- Total debt divided by shareholders' equity. Not given when equity is negative.
- Net debt
- Total debt less cash. Negative means more cash than debt.
- Net debt to EBITDA
- Debt less cash, divided by operating income plus depreciation and amortization: roughly the years of operating earnings needed to repay it.
- Interest cover
- Operating income divided by the interest paid on debt.
- Current ratio
- Assets due within a year divided by liabilities due within a year.
- Equity share of assets
- Shareholders' equity as a share of total assets.
- Free cash flow
- Cash from operations less capital spending.
- Free cash flow margin
- Free cash flow as a share of revenue.
- Cash conversion
- Cash from operations as a share of net income. Only when the year was profitable.
- Capital spending share of revenue
- Capital spending as a share of revenue.
- Buyback yield
- Shares bought back in the fiscal year as a share of today's market value.
- Shareholder yield
- Dividends plus buybacks as a share of today's market value.
- Change in share count
- Diluted shares against the year before. Negative: fewer shares.
- Asset turnover
- Revenue divided by total assets (average of the year).